105 results
Page 2 of 6
8-K
EX-99.1
e5kw4 hpnpj9h54v0
14 Feb 24
Other Events
9:22am
8-K
EX-99.1
52b3gw6anj
2 Jan 24
Pulse Biosciences Files 510(k) Submission with U.S. FDA for its CellFX® nsPFA™ Cardiac Clamp
9:20am
8-K
EX-99.1
n1ktx80af1inl
20 Dec 23
Pulse Biosciences Announces First-in-Human Procedures with its Novel CellFX™ Nanosecond Pulsed Field Ablation (nsPFA™) Cardiac Catheter
9:06am
8-K
EX-99.1
i0l5wirv scuyth
21 Nov 23
Pulse Biosciences Files 510(k) Submission with U.S. FDA for its CellFX nsPFA Percutaneous Electrode
9:03am
8-K
EX-99.1
9ju2r6 gsnzya4z0
13 Nov 23
Pulse Biosciences Reports Business Updates and Third Quarter 2023 Financial Results
9:12am
8-K
EX-99.1
2piwmdpskbpp
10 Aug 23
Pulse Biosciences Reports Business Updates and Second Quarter 2023 Financial Results
4:14pm
SD
EX-1.01
tuv o9fcey8
31 May 23
Conflict minerals disclosure
5:17pm
8-K
EX-99.1
n2m3wlsh xpky07h
11 May 23
Pulse Biosciences Reports Business Updates and First Quarter 2023 Financial Results
4:15pm
8-K
EX-99.1
8euz2
10 May 23
Pulse Biosciences, Inc. Announces Planned Redemption of Warrants
9:20am
8-K
EX-99.1
qlx4vi aeot9z
1 May 23
Pulse Biosciences Announces $65 Million Private Placement
4:15pm
8-K
EX-99.1
40ybx8yt0g
30 Mar 23
Pulse Biosciences Reports Fourth Quarter & Full Year 2022 Financial Results
4:15pm
8-K
EX-99.1
ev2zvuwdkd7oqblrg
10 Nov 22
Pulse Biosciences Reports Third Quarter 2022 Financial Results
4:20pm
8-K
EX-99.1
mhaj95i
23 Sep 22
Pulse Biosciences Announces Strategic Change of Focus in Support of Significant Additional Opportunities for medicinal related Nano-Pulse Stimulation
5:09pm